Bone marrow transplants offer surprising way to treat mitochondrial disease

A groundbreaking study led by Stanford Medicine has revealed that bone marrow transplants may provide a novel treatment approach for mitochondrial disorders. These genetic diseases affect the function of mitochondria, the cellular powerhouses responsible for energy production. In the study, published in Nature Communications, researchers found that providing a modified bone marrow transplant to mice with Friedreich's ataxia, a mitochondrial disorder, led to surprising benefits.

Healthy immune cells from the transplanted bone marrow migrated to tissues throughout the body, transferring their mitochondria to neighboring cells with failing mitochondria, thereby alleviating disease symptoms. This mechanism, known as mitophagy, allows cells to communicate and share functional mitochondria. Scientists are excited about the potential implications of this discovery, as it suggests that diseased cells can receive replacement parts from healthy cells through the blood system.

The findings offer hope for a first effective treatment for mitochondrial disorders, which affect about 1 in 5,000 people and typically first appear in childhood. Mitochondrial diseases are degenerative and can lead to severe health issues, including heart failure. Current treatments focus on reducing mitochondrial damage, but they do not address the underlying problem.

The study's lead author, Hyunmin Cho, Ph.D., notes that this research has significant implications for disease treatment, as cells are communicating in ways that were previously unrecognized.